Metronomic decitabine offers a patient-centered frontline therapeutic approach for TP53 -mutated complex-karyotype myeloid neoplasms
Jonathan A. Webster
Lukasz P. Gondek
Mark J. Levis
G. Ghiaur
Sandeep Kaduluri
Howard L. Li
Zachary B. Abrams
Philip R. O. Payne
Philip H. Imus
A. Ambinder
W. Dalton
Amy E. Dezern
Ivana Gojo
Tania Jain
Theodoros Karantanos
G. Prince
B. Smith
Metronomic
L. Walsh
Royce P. Lee
Joanathan Pan
Arun B. Dutta
V. Preetam
Theodoros Karatanos